ReviewFrontiers in immunology2023
RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications.
Dan Ke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled itcites it